nm23 Expression in choroidal melanoma

Ophthalmic Research

Volumn 32, Issue 6, 2000, Pages 257-260

  Bardak, Yavuz ^a,f   Çekiç, Osman ^b   Ayhan, Ayşe ^c   Günalp, Ilhan ^d   Bulay, Orhan ^e  

^a SULEYMAN DEMIREL UNIVERSITY SCHOOL OF MEDICINE   (Turkey)

^b SSK Ankara Eye Hospital   (Turkey)

^c HACETTEPE UNIVERSITY   (Turkey)

^d An ttepe Military Dispensary Clinic of Ophthalmology   (Turkey)

^e ANKARA UNIVERSITY   (Turkey)

^f NONE   (Turkey)

Author keywords

Choroidal melanoma; Metastasis suppressor gene; Mitotic figure; nm23; Nuclear grade; Prognosis; Tumour suppressor gene

Indexed keywords

ADULT; AGED; ARTICLE; CHOROID TUMOR; CLINICAL ARTICLE; EYE TUMOR; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MALE; MELANOMA; MELANOMA CELL; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; TUMOR SUPPRESSOR GENE; TUMOR VOLUME;

EID: 0033798372     PISSN: 00303747     EISSN: None     Source Type: Journal    
DOI: 10.1159/000055623     Document Type: Article

References (21)

1. Steeg PS, Bevilacqua G, Kopper L, Thorgeirsson UP, Talmadge JE, Liotta LA, Sobel ME: Evidence for a novel gene associated with low tumour metastatic potential. J Natl Cancer Inst 1988;80:200-204.
2. Bevilacqua G, Sobel ME, Liotta LA, Steeg PS: Association of low nm23 RNA levels in human primary infiltrating ductal breast carcinomas with lymph node involvement and other histopathological indicators of high metastatic potential. Cancer Res 1989;49:5185-5189.
3. Ayhan A, Yasui W, Yokosaki H, Kitadai Y, Tahara E: Reduced expression nm23 protein is associated with advanced tumour stage and distant metastasis in human colorectal carcinomas. Virehows Arch B Cell Pathol 1993;63: 213-218.
4. Gunduz M, Ayhan A, Gullu I, Onerei M, Hosal AS, Gursel B, Hosal IN, Firat D: nm23 protein expression in larynx cancer and relationship with metastasis. Eur J Cancer 1997;33:2338-2341.
5. Saraç E. Ayhan A, Ertoy D, Tuneer ZS, Yasui W, Tahara E, Ayhan A: nm23 expression in carcinoma of the uterine cervix. Em J Gynaccol Oncol 1998;19:312-315.
6. Ayhan A, Usuhütün A, Özen H, Yasui W, Tahara E: Reduced nm23 protein levels in renal cell tumours: The role of the cell type. Oncol Rep 1998;5:979-983.
7. Leone A, Seeger RC, Hong CM, Hu YY, Arboleda MJ, Brodeur GM, Stram D, Slamon DJ, Steeg PS: Evidence for nm23 RNA overexpression. DNA amplification and mutation in aggressive childhood neuroblastoma. Oncogene 1993;8:855-865.
8. Egan KM, Seddon JM, Glynn RJ, Gragoudas ES, Albert DM: Epidemiologic aspects of uveal melanoma. Surv Ophthalmol 1988;32:239-251.
9. McLean IW, Foster WD, Zimmerman LE: Uveal melanoma: Localization, size, cell type and enucleation as risk factors in metastasis. Hum Pathol 1982;13:123-132.
10. Rajpal S, Moore R, Karakousis CP: Survival in metastatic ocular melanoma. Cancer 1983;52: 334-336.
11. Callender GR: Malignant melanotic tumours of the eye: A study of histologic types in 111 cases. Trans Am Acad Ophthalmol Otolaryngol 1931;36:131-142.
12. Folberg R, Gamel JW, Greenberg RA, Donoso LA, Naids RM: Comparison of direct and microslide pathology measurements of uveal melanomas. Invest Ophthalmol Vis Sci 1985;26: 1788-1791.
13. COMS report No. 6: Histopathologic characteristics of uveal melanomas in eyes enucleated from the Collaborative Ocular Melanoma Study. Am J Ophthalmol 1998;125:745-766.
14. Aihara M, Truong LD, Dunn JK, Wheeler TM, Scardino PT, Thompson TC: Frequency of apoptotic bodies positively correlates with Gleason grade in prostate cancer. Hum Pathol 1994;25:797-801.
15. Aral T, Kino I: Role of apoptosis in modulation of the growth of human colorectal tubular and villous adenomas. J Pathol 1995;176:37-44.
16. Sagon O: Apoptotic and mitotic index in aquamous cell carcinomas and premalignant lesions of the uterine cervix. Int J Surg Pathol 1999;7: 155.
17. Elder DE, Murphy GF: Atlas of Tumor Pathology: Melanocytic Tumors of the Skin. Washington, Armed Forces Institute of Pathology, 1991, p 159.
18. Gilles AM, Presecan E, Vonica A, Lascus I: Nucleoside diphosphate from human erythrocytes: Structural characterization of the two polypeptide chains responsible for heterogeneity of the hexameric enzyme. J Biol Chem 1991;266:8784-8789.
19. Gamel JW, McLean IW, Greenberg RA, Zimmerman LE, Lichtenstein SJ: Computerized histologic assessment of malignant potential: A method for determining the prognosis of uveal melanomas. Hum Pathol 1982;13:893-897.
20. McCurdy J, Gamel J, McLean IW: A simple, efficient and reproducible method for estimating the malignant potential of uveal melanoma from routine HE slides. Pathol Res Pract 1991; 187:1025-1027.
21. Folberg R, Peter J, Gruman IM, Woolson RF, Jeng G, Montague PR, Moninger TO, Yi H, Moore KC: The morphologic characteristics of tumour blood vessels as a marker of tumour progression in primary human uveal melanoma: A matched case-control study. Hum Pathol 1992;23:1298-1305.